文献
J-GLOBAL ID:201902292023201959
整理番号:19A0980667
TAK1,NF-κBおよびSTAT3のダウンレギュレーションを介したヒトトリプルネガティブ乳癌細胞に対するノル-wogonin(5, 7, 8-トリヒドロキシフラボンの抗癌効果【JST・京大機械翻訳】
Anticancer effect of nor-wogonin (5, 7, 8-trihydroxyflavone) on human triple-negative breast cancer cells via downregulation of TAK1, NF-κB, and STAT3
著者 (20件):
Abd El-Hafeez Amer Ali
(Pharmacotherapy Department, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan)
,
Abd El-Hafeez Amer Ali
(Global Career Design Center, Hiroshima University, Hiroshima, Japan)
,
Abd El-Hafeez Amer Ali
(Pharmacology and Experimental Oncology Unit, Cancer Biology Department, National Cancer Institute, Cairo University, Cairo, Egypt)
,
Khalifa Hazim O.
(Department of Pharmacology, Faculty of Veterinary Medicine, Kafrelsheikh University, Kafrelsheikh, Egypt)
,
Khalifa Hazim O.
(Department of Infectious Diseases, Graduate School of Medicine, International University of Health and Welfare, Narita, Japan)
,
Mahdy Elham A.M.
(Faculty of Pharmacy, Beni-Suef University, Beni-Suef, Egypt)
,
Sharma Vikas
(Pharmacology Department, Case Western Reserve University School of Medicine, Cleveland, OH, USA)
,
Hosoi Toru
(Pharmacotherapy Department, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan)
,
Ghosh Pradipta
(Department of Medicine, University of California, San Diego, La Jolla, CA,USA)
,
Ghosh Pradipta
(Department of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, CA, USA)
,
Ghosh Pradipta
(Moores Cancer Center, University of California, San Diego, La Jolla, CA, USA)
,
Ozawa Koichiro
(Pharmacotherapy Department, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan)
,
Montano Monica M.
(Pharmacology Department, Case Western Reserve University School of Medicine, Cleveland, OH, USA)
,
Fujimura Takashi
(Hiroshima Research Center for Healthy Aging (HiHA), Department of Molecular Biotechnology, Graduate School of Advanced Sciences of Matter, Hiroshima University, Hiroshima, Japan)
,
Ibrahim Ahmed R.N.
(Department of Biochemistry, Faculty of Pharmacy, Minia University, Minia, Egypt)
,
Abdelhamid Mohamed A.A.
(Department of Botany and Microbiology, Faculty of Science, Minia University, Minia Egypt)
,
Abdelhamid Mohamed A.A.
(Department of Biotechnology and Bioinformatics, Korea University, Sejong, Republic of Korea)
,
Pack Seung Pil
(Department of Biotechnology and Bioinformatics, Korea University, Sejong, Republic of Korea)
,
Shouman Samia A.
(Pharmacology and Experimental Oncology Unit, Cancer Biology Department, National Cancer Institute, Cairo University, Cairo, Egypt)
,
Kawamoto Seiji
(Hiroshima Research Center for Healthy Aging (HiHA), Department of Molecular Biotechnology, Graduate School of Advanced Sciences of Matter, Hiroshima University, Hiroshima, Japan)
資料名:
Pharmacological Reports
(Pharmacological Reports)
巻:
71
号:
2
ページ:
289-298
発行年:
2019年
JST資料番号:
A1528A
ISSN:
1734-1140
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)